ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,958Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 387

$701K Total Retail Price of All Prescriptions

Rank: 72 out of 387

664 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 664 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 664 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 8,086 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 293 147 S3 1 1
SIMVASTATIN 286 265 2 5
FUROSEMIDE 273 234 3 7
OMEPRAZOLE 265 218 4 4
LEVOTHYROXINE SODIUM 241 222 5 2
METFORMIN HCL 241 223 5 8
ATORVASTATIN CALCIUM 236 214 7 13
AMLODIPINE BESYLATE 222 214 8 6
HYDROCHLOROTHIAZIDE 208 193 9 12
GABAPENTIN 206 158 10 10
ATENOLOL 205 181 11 20
WARFARIN SODIUM 190 157 12 17
LISINOPRIL 170 150 13 3
ENALAPRIL MALEATE 160 129 14 69
PRAVASTATIN SODIUM 158 140 15 15
TRAMADOL HCL 153 109 16 14
ZOLPIDEM TARTRATE 151 120 17 16
CLOPIDOGREL 150 138 18 25
LOSARTAN POTASSIUM 146 126 19 24
CARVEDILOL 128 107 20 21
POTASSIUM CHLORIDE 119 105 21 9
CYMBALTA 114 67 22 44
PLAVIX 104 97 23 39
METOPROLOL TARTRATE 100 88 24 11
GLIMEPIRIDE 99 86 25 50
DONEPEZIL HCL 90 85 26 27
MELOXICAM 90 82 26 22
LOSARTAN-HYDROCHLOROTHIAZIDE 89 82 28 65
CITALOPRAM HBR 87 73 29 19
SPIRIVA 83 65 30 61
LANTUS 83 47 30 51
FLUTICASONE PROPIONATE 81 66 32 29
SUCRALFATE 80 70 33 128
ADVAIR DISKUS 80 65 33 41
PANTOPRAZOLE SODIUM 79 72 35 48
NEXIUM 78 64 36 26
ALLOPURINOL 75 72 37 28
DICLOFENAC SODIUM 73 63 38 115
CIPROFLOXACIN HCL 71 54 39 56
AMITRIPTYLINE HCL 70 45 R 40 62
TAMSULOSIN HCL 69 65 41 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 65 41 30
CYCLOBENZAPRINE HCL 66 37 R 43 42
DIGOXIN 60 48 44 40
LYRICA 58 19 45 66
ROPINIROLE HCL 58 55 45 91
SERTRALINE HCL 56 49 47 23
DOXAZOSIN MESYLATE 56 50 47 75
KLOR-CON 10 53 47 49 124
PREDNISONE 53 46 49 43
VENLAFAXINE HCL 52 44 51 207
PAROXETINE HCL 52 43 51 52
PROAIR HFA 50 43 53 47
CRESTOR 50 46 53 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.